SFI
CRBU icon

Susquehanna Fundamental Investments’s Caribou Biosciences CRBU Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,027
Closed -$18.3K – 786
2025
Q1 		$18.3K Sell
20,027
-160,796
-89% -$209K ﹤0.01% 1052
2024
Q4 		$288K Buy
+180,823
New +$364K ﹤0.01% 951
2024
Q2 		$27.8K Sell
16,967
-91,637
-84% -$293K ﹤0.01% 919
2024
Q1 		$558K Buy
+108,604
New +$670K 0.03% 449
2023
Q3 		– Sell
-24,752
Closed -$105K – 418
2023
Q2 		$105K Sell
24,752
-18,627
-43% -$83.7K ﹤0.01% 605
2023
Q1 		$230K Sell
43,379
-8,234
-16% -$51.3K 0.01% 838
2022
Q4 		$324K Buy
+51,613
New +$459K 0.01% 975

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's CRBU Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 20,027 shares — an estimated $18.3K sold.

Susquehanna Fundamental Investments first reported a position in CRBU in Q4 2022 and held it in 7 quarters. The position peaked at $558K in Q1 2024. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 20,027 Caribou Biosciences shares in Q2 2025, an estimated $18.3K.
  • Susquehanna Fundamental Investments first reported a position in Caribou Biosciences in Q4 2022 and held it in 7 quarters.
  • Susquehanna Fundamental Investments's Caribou Biosciences position peaked at $558K in Q1 2024.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.